Nelson Peltz Very High on Aurora Cannabis

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nelson Peltz Very High on Aurora Cannabis

© Dmitry_Tishchenko / Getty Images

News that Aurora Cannabis Inc. (NYSE: ACB) has appointed the notorious activist investor Nelson Peltz as a strategic advisor boosted shares early on Wednesday.

Management is hoping to work collaboratively with Peltz and strategically explore potential partnerships that would be the optimal strategic fit for successful entry into each of Aurora’s contemplated market segments. Peltz also will advise on the company’s global expansion strategy.

Some quick background: Peltz is the chief executive officer and a founding partner of Trian Fund Management, a multi-billion-dollar investment management firm. Peltz also currently serves as the nonexecutive chair of Wendy’s and as a director of Procter & Gamble, Sysco and Madison Square Garden.

In consideration for the services to be provided as a senior advisor, Aurora Cannabis has granted options to Peltz to purchase 19,961,754 common shares in the company at a certain price. The options will vest ratably over a four-year period on a quarterly basis, subject to accelerated vesting based on the occurrence of certain specified events.

[nativounit]

CEO Terry Booth commented:

Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many industry verticals that are of great interest to us. Like us, Nelson also takes a long-term view of value creation to benefit all stakeholders. We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact.

Shares of Aurora were last seen up about 10% at 8.75 on Wednesday, in a 52-week range of $4.05 to $12.52.

[recirclink id=534043]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618